Septmeber 17, 2020: Acella Pharmaceuticals Issues Thyroid Tablet Recall Due To Sub Potency Sep 17 2020 June 15, 2020: COVID-19 Update: FDA Revokes Emergency Use Authorization for chloroquine phosphate and hydroxychloroquine sulfate Jun 15 2020 The products subject to recall are packed in 100-count bottles. Acella said that the thirteen lots of NP Thyroid ® recalled are in 100-unit bottles containing either 30-mg, 60-mg, or 90-mg tablets. Consumers with questions can email Acella Pharmaceuticals at recall@acellapharma.com or contact 1-888-280-2044 Monday through Friday from 8 a.m. to 5 p.m. The Food and Drug Administration (FDA) recently announced a recall of two thyroid medications, because they pose health dangers to consumers. Septmeber 17, 2020: Acella Pharmaceuticals Issues Thyroid Tablet Recall Due To Sub Potency Acella Pharmaceutical Thyroid Tablet Recall announced on September 17, 2020. This means that these products were too weak and therefore ineffective in fully treating hypothyroidism. Acella Pharmaceuticals, LLC recalled NP Thyroid tablets after testing found the lots to be "sub potent," the FDA said. Acella Pharmaceuticals is recalling 13 lots of their NP Thyroid medicine since it was found to be superpotent. (Gray News) - The U.S. Food and Drug Administration issued a recall notice for Acella Pharmaceuticals, LLC for two lots of medicine for people with hypothyroidism. The recalled lot numbers are as follows: M3229A19-1, M329H18- M329J18-1, M329J18-2, M329J18-3, M329M18-2, M330J182A, M330J18-3, M33G18-1, M331J18-2, M31M18-1, and M331M18-2. On Sept. 17, 2020, Acella Pharmaceuticals further announced that one lot of 15 mg and one lot of 120 mg NP Thyroid (thyroid tablets, USP) are being recalled because testing has found these lots to be subpotent. Consumers may file a lawsuit even if the pharmaceutical company issues a recall for potentially harmful medication or medical device. English; Español Acella Pharmaceuticals, LLC recalled one lot each of the company’s 15-mg and 120-mg NP Thyroid®, Thyroid Tablets, after testing found these lots to be sub potent. Consumers with questions can email Acella Pharmaceuticals at recall@acellapharma.com or contact 1-888-280-2044 Monday ... Wisconsin high court declines to hear Trump election lawsuit… NP Thyroid 15 & NP Thyroid 120 Tablets have been recalled by Acella Pharmaceuticals, LLC due to sub-potent amounts of levothyroxine (T4). ... UPDATE: AND NOW A LAWSUIT: You can read about it here. Acella Pharmaceuticals is recalling 13 lots of NP Thyroid ® – a drug used to treat hypothyroidism – for being “super potent.” According to the recall announcement posted by the U.S. Food and Drug Administration (FDA), the affected lots of NP Thyroid ® contain up to 115 percent of one of the drug’s active ingredients. Thyroid news report: On May 22nd, 2020 Acella Pharmaceuticals issued a voluntary nationwide recall of certain lots of NP thyroid due to superpotency.. Don't worry, I'm going to explain in plain English what this all means and how it applies to you. Acella Pharmaceuticals’ FDA-posted recall notice says testing determined 13 lots of its NP Thyroid tablets in 30 mg, 60 mg and 90 mg strengths were super potent. September 3, 2020 Ohio Legal Updates, Ohio Products Liability. Acella Pharmaceuticals, Llc Hydroquinone 4% | Acella Pharmaceuticals, Llc HYDROQUINONE 4% CREAM should be applied to affected areas and rubbed in well twice daily, in the morning and before bedtime, or as directed by a physician. The voluntary recall of NP Thyroid by Acella Pharmaceuticals, LLC. To date, Acella has received two reports of adverse events related to this recall. ABOUT ACELLA and NP THYROID: Acella Pharmaceuticals, LLC is a specialty pharmaceutical company. Consumers with questions can email Acella Pharmaceuticals at recall@acellapharma.com or contact 1-888-280-2044 Monday through Friday from 8 a.m ... Trump files lawsuit … Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency Share Updated: May 22, 2020 - 3:00 PM WASHINGTON, D.C. — Acella Pharmaceuticals, LLC (Acella), with the consent of the U.S. Food and Drug Administration (FDA) announced it would recall thirteen lots of NP Thyroid ® because one of the two active ingredients is super-potent.The generic name for the recalled drugs is thyroid tablets, USP. In May, Acella Pharmaceuticals also issued a voluntary nationwide recall of 13 lots of NP Thyroid tablets due to what the FDA called a super potency. What have hypothyroid patients been moving over to. Did Your Pet Suffer From Sportmix Aflatoxin Injuries? ET. Alaris™ Syringe and Alaris™ PCA Modules have been recalled by Becton, Dickinson and Company (BD) because of possible display errors that can result in over- or under-infusion. So far, Acella says it has received four reports of "adverse events" for these lot numbers, possibly related to the recall. ET. In May, Acella Pharmaceuticals also issued a voluntary nationwide recall of 13 lots of NP Thyroid tablets due to what the FDA called a super potency. The recall has been issued after testing confirmed that the products were sub potent. The Acella Pharmaceuticals recall may be the most recent one, but it is not the only one of its kind. Thyroid Medication Recalled Due to Incorrect Dosage. Before them, a manufacturer called RLC Labs 483 lots of two thyroid medications, Nature-Thyroid and WPThyroid for the same reason: sub-potency. Lawsuit … COMPANY ANNOUNCEMENT – Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall May 22, 2020: “Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. Ramos Furniture Class Action Lawsuit; Exempt Misclassifications; Consumer Class Actions; Consumer Fraud; On Call Shifts; Employment Class Actions; Unpaid Overtime; Personal Injury. Personal Injury Practice; Contact Us; Select Language. Consumers with questions can email Acella Pharmaceuticals at recall@acellapharma.com or contact 1-888-280-2044 Monday through Friday from 8 a.m. to 5 p.m. The recall affects 37 unexpired lots of levothyroxine and liothyronine (Thyroid Tablets, USP) 15, 30, 60, 90 and 120 milligrams. Acella Pharmaceuticals has announced its recent recall on their NP thyroid tablets. Its desiccated thyroid called NP Thyroid came out around 2010. Acella Pharmaceuticals is recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets [levothyroxine (T4) and liothyronine (T3)]. I’m angry 2 years of my life were lived so miserably because of this medication! Patients and pharmacists can identify the drugs based on the following information: The recall includes one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets [levothyroxine (T4) and liothyronine (T3)]. Acella Pharmaceuticals, LLC. Acella Pharmaceuticals, LLC has issued a recall of one lot of 15 mg NP Thyroid tablets and another lot of 120 mg NP Thyroid tablets after tests found they did not contain an adequate amount of levothyroxine (T4). One lot of 15-mg and one lot of 120-mg NP Thyroid tablets, USP [levothyroxine (T4) … NP Thyroid (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. Other Information. Acella Pharmaceuticals NP Thyroid Tablets Recall. On May 22, 2020, the U.S. Food and Drug Administration (FDA) posted an announcement on its website indicating that Acella Pharmaceuticals, LLC is recalling 13 lots of NP Thyroid tablets. Acella Pharmaceuticals, the manufacturer of NP Thyroid 15 and NP Thyroid 120, voluntarily recalled these … COMPANY ANNOUNCEMENT – Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall May 22, 2020: “Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. Acella has reportedly received four reports of adverse events related to the affected lots. NP Thyroid Recall by Acella. They contain both tetraiodothyronine sodium (T4 levothyroxine) and triiodothyronine sodium (T3 liothyronine) providing 38 mcg levothyroxine (T4) and 9 mcg liothyronine (T3) per grain of thyroid (or per 65 mg of the labeled amount of thyroid). One lot of the 15 mg dosage and one lot of the 120 mg dosage are affected by the recall.